Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mineralys Therapeutics, Inc. - Common Stock
(NQ:
MLYS
)
13.50
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Mineralys Therapeutics, Inc. - Common Stock
< Previous
1
2
Next >
Unusual volume stocks are being observed in Wednesday's session.
March 12, 2025
Which stocks have an unusual volume on Wednesday?
Via
Chartmill
Hello Group, loanDepot, Mineralys Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
March 12, 2025
Via
Benzinga
Keep an eye on the top gainers and losers in Monday's session.
March 10, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Monday's session: top gainers and losers
March 10, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Earnings Scheduled For February 12, 2025
February 12, 2025
Via
Benzinga
Insights into Mineralys Therapeutics's Upcoming Earnings
November 08, 2024
Via
Benzinga
Mineralys Therapeutics Earnings Preview
March 20, 2024
Via
Benzinga
Where Mineralys Therapeutics Stands With Analysts
May 16, 2023
Via
Benzinga
Mineralys Therapeutics Unveils Positive Data From Two Trials For Hypertension Drug Candidate
March 10, 2025
Mineralys Therapeutics' lorundrostat met key Phase 3 and Phase 2 trial endpoints for hypertension, showing significant blood pressure reductions and a strong safety profile.
Via
Benzinga
Dow Tumbles Over 600 Points; Mineralys Therapeutics Shares Spike Higher
March 10, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Let's uncover which stocks are experiencing notable gaps during today's session.
March 10, 2025
The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Redfin, Mineralys Therapeutics, Trevi Therapeutics And Other Big Stocks Moving Higher On Monday
March 10, 2025
Via
Benzinga
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket
March 10, 2025
Via
Benzinga
Which stocks are moving after the closing bell on Friday?
March 07, 2025
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
Ford, Skyworks Solutions, FormFactor And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
February 06, 2025
Via
Benzinga
Why F5 Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
January 29, 2025
Via
Benzinga
Ericsson Posts Weak Results, Joins East West Bancorp And Other Big Stocks Moving Lower In Friday's Pre-Market Session
January 24, 2025
Via
Benzinga
Why Twilio Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
January 24, 2025
Via
Benzinga
Earnings Scheduled For November 11, 2024
November 11, 2024
Via
Benzinga
MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q2 2024
August 13, 2024
MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
MLYS Stock Earnings: Mineralys Therapeutics Misses EPS for Q1 2024
May 09, 2024
MLYS stock results show that Mineralys Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
MLYS Stock Earnings: Mineralys Therapeutics Beats EPS for Q4 2023
March 21, 2024
MLYS stock results show that Mineralys Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For March 21, 2024
March 21, 2024
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million.
Via
Benzinga
Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday
February 08, 2024
U.S. stocks traded mixed, with the Dow Jones gaining around 20 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 08, 2024
Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 08, 2024
Via
Benzinga
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.
Via
Benzinga
$5M Bet On TreeHouse Foods? Check Out These 3 Stocks Insiders Are Buying
September 11, 2023
Although U.S. stocks closed higher on Friday, there were a few notable insider trades.
Via
Benzinga
The Acute Hospital Care Market Is Worth Over $3 Trillion, And Windtree Therapeutics Brings A First-In-Class Drug To An Active Segment Of This Market
July 17, 2023
The global acute hospital care market was worth $3.2 trillion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.62% from 2023 to 2030.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
On Tuesday, 74 companies achieved new lows for the year.
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.